Difference between revisions of "Team:Uppsala"

Line 126: Line 126:
 
<img src="https://static.igem.org/mediawiki/2017/4/4a/Test_crtIEBZY_2.jpg" style="display: block; margin: auto; width:40%; height: auto; padding-bottom:3%">
 
<img src="https://static.igem.org/mediawiki/2017/4/4a/Test_crtIEBZY_2.jpg" style="display: block; margin: auto; width:40%; height: auto; padding-bottom:3%">
 
<br><br>
 
<br><br>
The crocin pathway is poorly characterized and our <a href="https://static.igem.org/mediawiki/2017/d/d8/Uppsala-Market-analysis.pdf" target="_blank">market analysis</a> on saffron shows that the compounds in the pathway are very expensive due to the labour-intensive harvest. By using synthetic biology for recombinant expression in <i>Escherichia Coli</i> we could reduce the price of the compounds within the crocin pathway and open up the possibility for industrial and medicinal applications to be further explored. To develop our project further, we have done extensive <a href="https://2017.igem.org/Team:Uppsala/Model">homology modeling, molecular dynamics and kinetic measurements</a> to characterize the enzymes in our pathway. When working with recombinant microorganisms, and as well when introducing a new manufacturing method to the saffron market, we realized it was very important for us to take <a href="https://2017.igem.org/Team:Uppsala/HP/Gold_Integrated">ethical aspects</a> into account. To understand the ethical concerns further we spoke to experts, collaborated with other iGEM teams and organized events for the public.</div>
+
The crocin pathway is poorly characterized and our <a href="https://static.igem.org/mediawiki/2017/d/d8/Uppsala-Market-analysis.pdf" target="_blank">market analysis</a> on saffron shows that the compounds in the pathway are very expensive due to the labour-intensive harvesting process. By using synthetic biology for recombinant expression in <i>Escherichia Coli</i> we could reduce the price of the compounds within the crocin pathway and open up the possibility for industrial and medicinal applications to be further explored. To develop our project further, we have done extensive <a href="https://2017.igem.org/Team:Uppsala/Model">homology modeling, molecular dynamics and kinetic measurements</a> to characterize the enzymes in our pathway. When working with recombinant microorganisms, and as well when introducing a new manufacturing method to the saffron market, we realized it was very important for us to take <a href="https://2017.igem.org/Team:Uppsala/HP/Gold_Integrated">ethical aspects</a> into account. To understand the ethical concerns further we spoke to experts, collaborated with other iGEM teams and organized events for the public.</div>
  
 
<div class="somethingsomething"> Our achievements this year are:</div>
 
<div class="somethingsomething"> Our achievements this year are:</div>
 
<div class="somethingsomething"> 1. We successfully integrated the first five steps of the crocin pathway from FPP to zeaxanthin into the <i>E. coli</i> chromosome. The result is a <i>E. coli</i> strain expressing <a href="https://2017.igem.org/Team:Uppsala/Zea-Strain">zeaxanthin</a>.</div>
 
<div class="somethingsomething"> 1. We successfully integrated the first five steps of the crocin pathway from FPP to zeaxanthin into the <i>E. coli</i> chromosome. The result is a <i>E. coli</i> strain expressing <a href="https://2017.igem.org/Team:Uppsala/Zea-Strain">zeaxanthin</a>.</div>
<div class="somethingsomething"> 2. We have created sequenced verified <a href="https://2017.igem.org/Team:Uppsala/Parts">BioBricks</a> of the three last enzymes in the crocin pathway: <a href="https://2017.igem.org/Team:Uppsala/CrocinPathway">CaCCD2, CsADH2946 and UGTCs2</a>. We have also characterized these enzymes with <a href="https://2017.igem.org/Team:Uppsala/CrocinPathway">experiments</a> and <a href="https://2017.igem.org/Team:Uppsala/Model">simulations</a></div>
+
<div class="somethingsomething"> 2. We have created sequenced verified <a href="https://2017.igem.org/Team:Uppsala/Parts">BioBricks</a> of the three last enzymes in the crocin pathway: <a href="https://2017.igem.org/Team:Uppsala/CrocinPathway">CaCCD2, CsADH2946 and UGTCs2</a>. We have also characterized these enzymes with <a href="https://2017.igem.org/Team:Uppsala/CrocinPathway">experiments</a> and <a href="https://2017.igem.org/Team:Uppsala/Model">simulations</a>.</div>
 
<div class="somethingsomething"> 3. We are the first to purify and confirm activity of <a href="https://2017.igem.org/Team:Uppsala/CrocinPathway"><i>Crocus Sativus</i> aldehyde hydrogenase (CsADH2946)</a> as well as measuring the <a href="https://2017.igem.org/Team:Uppsala/Model">kinetic parameters</a> of the enzyme.</div>
 
<div class="somethingsomething"> 3. We are the first to purify and confirm activity of <a href="https://2017.igem.org/Team:Uppsala/CrocinPathway"><i>Crocus Sativus</i> aldehyde hydrogenase (CsADH2946)</a> as well as measuring the <a href="https://2017.igem.org/Team:Uppsala/Model">kinetic parameters</a> of the enzyme.</div>
 
<div class="somethingsomething"> 4. Finally we have combined the zeaxanthin producing strain with a plasmid containing all three enzymes from zeaxanthin to crocin, thus we successfully constructed a bacterial strain with all the genes needed to produce <a href="https://2017.igem.org/Team:Uppsala/Results">crocin and the pathway components</a>.</div>
 
<div class="somethingsomething"> 4. Finally we have combined the zeaxanthin producing strain with a plasmid containing all three enzymes from zeaxanthin to crocin, thus we successfully constructed a bacterial strain with all the genes needed to produce <a href="https://2017.igem.org/Team:Uppsala/Results">crocin and the pathway components</a>.</div>
<div> Join us and learn more about the exciting journey we have taken by discovering all our wiki page has to offer!</div>
+
<div> Join us and learn more about the exciting journey we have taken by discovering what all our wiki page has to offer!</div>
  
  

Revision as of 20:09, 1 November 2017

Crafting Crocin